Take2 Technologies Limited v. Pacific Biosciences of California, Inc.

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 SAN JOSE DIVISION 7 8 TAKE2 TECHNOLOGIES LIMITED, et Case No. 23-cv-04166-EJD al., 9 ORDER DENYING DEFENDANT’S Plaintiffs, MOTION TO DISMISS 10 v. 11 Re: ECF Nos. 13, 14

PACIFIC BIOSCIENCES OF

12 CALIFORNIA INC, Defendant. 13 14 15 Plaintiffs Take2 Technologies Limited (“Take2”) and The Chinese University of Hong 16 Kong (“CUHK” and, with Take2, “Plaintiffs”) bring this action against Defendant Pacific 17 BioSciences of California, Inc. (“PacBio” or “Defendant”) for infringement of United States 18 Patent No. 11,091,794 (the “’794 Patent” or the “Patent-in-Suit”) in violation of 35 U.S.C. § 271. 19 See Compl., ECF No. 2. Now pending before the Court is Defendant’s motion to dismiss 20 Plaintiffs’ Complaint (the “Motion”) pursuant to Federal Rule of Civil Procedure 12(b)(6), in 21 which Defendant argues that the ’794 Patent is ineligible for patenting under 35 U.S.C. § 101. See 22 Mot., ECF No. 13; Mem. P. & A. (“MPA”), ECF No.…